Casanova Bruno F, Sammel Mary D, Macones George A
Department of Obstetrics and Gynecology, Pennsylvania Hospital, University of Pennsylvania, 800 Spruce Street, Philadelphia, PA 19107, USA.
J Reprod Med. 2005 Sep;50(9):663-8.
To evaluate the failure rate of a trial of vaginal birth in women with singleton pregnancies and 1 prior cesarean section who reported using cocaine during the current pregnancy.
The medical records of 9254 women who attempted a vaginal birth after cesarean (VBAC) at 16 community and tertiary care hospitals were retrospectively reviewed. VBAC was considered a failure if a woman who was initially considered suited to a trial of VBAC for whatever reason did not succeed in vaginal delivery and had to undergo a repeat cesarean section. We used stratified analysis as well as forward and backward logistic regression analysis to assess the relation between cocaine use during pregnancy and VBAC failure.
Thirteen percent of patients who reported using cocaine had a significant 59% decrease in the odds for VBAC failure in the unadjusted analysis (OR = 0.41, 95% CI= 0.29-0.58) as compared to those who did not report using this substance. Nevertheless, after adjusting for other important predictors of failure and possible confounding variables, the use of cocaine in our final model showed no difference in the odds for VBAC failure (OR = 0.74, 95% CI = 0.49-1.13) as compared to the odds in women who did not report using the drug.
We could not find any statistically significant difference in the odds for VBAC failure between patients who reported cocaine use during pregnancy and patients who reported those who did not.
评估单胎妊娠且既往有一次剖宫产史、在本次妊娠期间报告使用可卡因的女性经阴道分娩试验的失败率。
回顾性分析了16家社区医院和三级医疗机构中9254例尝试剖宫产术后阴道分娩(VBAC)的女性的病历。如果一名最初被认为适合进行VBAC试验的女性,无论出于何种原因,未能成功进行阴道分娩而不得不接受再次剖宫产,则VBAC被视为失败。我们采用分层分析以及向前和向后逻辑回归分析来评估孕期使用可卡因与VBAC失败之间的关系。
在未经调整的分析中,报告使用可卡因的患者中,VBAC失败几率显著降低了59%(OR = 0.41,95%CI = 0.29 - 0.58),而未报告使用该物质的患者则不然。然而,在对其他重要的失败预测因素和可能的混杂变量进行调整后,在我们的最终模型中,与未报告使用该药物的女性相比,使用可卡因的患者VBAC失败几率没有差异(OR = 0.74,95%CI = 0.49 - 1.13)。
我们发现,在妊娠期间报告使用可卡因的患者与未报告使用可卡因的患者之间,VBAC失败几率没有任何统计学上的显著差异。